146 related articles for article (PubMed ID: 30340109)
1. Pregnancy-associated plasma protein-A in atherosclerosis: Molecular marker, mechanistic insight, and therapeutic target.
Yu XH; He LH; Gao JH; Zhang DW; Zheng XL; Tang CK
Atherosclerosis; 2018 Nov; 278():250-258. PubMed ID: 30340109
[TBL] [Abstract][Full Text] [Related]
2. PAPP-A and the IGF system in atherosclerosis: what's up, what's down?
Steffensen LB; Conover CA; Oxvig C
Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H1039-H1049. PubMed ID: 31518159
[TBL] [Abstract][Full Text] [Related]
3. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury.
Resch ZT; Simari RD; Conover CA
Endocrinology; 2006 Dec; 147(12):5634-40. PubMed ID: 16959843
[TBL] [Abstract][Full Text] [Related]
4. Stanniocalcin-1 Potently Inhibits the Proteolytic Activity of the Metalloproteinase Pregnancy-associated Plasma Protein-A.
Kløverpris S; Mikkelsen JH; Pedersen JH; Jepsen MR; Laursen LS; Petersen SV; Oxvig C
J Biol Chem; 2015 Sep; 290(36):21915-24. PubMed ID: 26195635
[TBL] [Abstract][Full Text] [Related]
5. Local IGF Bioactivity Associates with High PAPP-A Activity in the Pericardial Cavity of Cardiovascular Disease Patients.
Hjortebjerg R; Rasmussen LM; Gude MF; Irmukhamedov A; Riber LP; Frystyk J; De Mey JGR
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32875328
[TBL] [Abstract][Full Text] [Related]
6. Effects of mutated pregnancy-associated plasma protein-a on atherosclerotic lesion development in mice.
Boldt HB; Bale LK; Resch ZT; Oxvig C; Overgaard MT; Conover CA
Endocrinology; 2013 Jan; 154(1):246-52. PubMed ID: 23161866
[TBL] [Abstract][Full Text] [Related]
7. [Association between IGF system and PAPP-A in coronary atherosclerosis].
Fierro-Macías AE; Floriano-Sánchez E; Mena-Burciaga VM; Gutiérrez-Leonard H; Lara-Padilla E; Abarca-Rojano E; Fierro-Almanzán AE
Arch Cardiol Mex; 2016; 86(2):148-56. PubMed ID: 26906607
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy-associated plasma protein-A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism.
Kumar A; Mohan S; Newton J; Rehage M; Tran K; Baylink DJ; Qin X
J Biol Chem; 2005 Nov; 280(45):37782-9. PubMed ID: 16115888
[TBL] [Abstract][Full Text] [Related]
9. Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol.
Conover CA; Bale LK; Harrington SC; Resch ZT; Overgaard MT; Oxvig C
Am J Physiol Cell Physiol; 2006 Jan; 290(1):C183-8. PubMed ID: 16338976
[TBL] [Abstract][Full Text] [Related]
10. MiR-490-3p modulates the proliferation of vascular smooth muscle cells induced by ox-LDL through targeting PAPP-A.
Sun Y; Chen D; Cao L; Zhang R; Zhou J; Chen H; Li Y; Li M; Cao J; Wang Z
Cardiovasc Res; 2013 Nov; 100(2):272-9. PubMed ID: 23821525
[TBL] [Abstract][Full Text] [Related]
11. PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway.
Tang SL; Chen WJ; Yin K; Zhao GJ; Mo ZC; Lv YC; Ouyang XP; Yu XH; Kuang HJ; Jiang ZS; Fu YC; Tang CK
Atherosclerosis; 2012 Jun; 222(2):344-54. PubMed ID: 22503545
[TBL] [Abstract][Full Text] [Related]
12. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability.
Dauber A; Muñoz-Calvo MT; Barrios V; Domené HM; Kloverpris S; Serra-Juhé C; Desikan V; Pozo J; Muzumdar R; Martos-Moreno GÁ; Hawkins F; Jasper HG; Conover CA; Frystyk J; Yakar S; Hwa V; Chowen JA; Oxvig C; Rosenfeld RG; Pérez-Jurado LA; Argente J
EMBO Mol Med; 2016 Apr; 8(4):363-74. PubMed ID: 26902202
[TBL] [Abstract][Full Text] [Related]
13. Insulin-Like Growth Factor Bioactivity, Stanniocalcin-2, Pregnancy-Associated Plasma Protein-A, and IGF-Binding Protein-4 in Pleural Fluid and Serum From Patients With Pulmonary Disease.
Espelund US; Bjerre M; Hjortebjerg R; Rasmussen TR; Lundby A; Hoeflich A; Folkersen BH; Oxvig C; Frystyk J
J Clin Endocrinol Metab; 2017 Sep; 102(9):3526-3534. PubMed ID: 28911149
[TBL] [Abstract][Full Text] [Related]
14. Stanniocalcin-2 overexpression reduces atherosclerosis in hypercholesterolemic mice.
Steffensen LB; Conover CA; Bjørklund MM; Ledet T; Bentzon JF; Oxvig C
Atherosclerosis; 2016 May; 248():36-43. PubMed ID: 26983002
[TBL] [Abstract][Full Text] [Related]
15. IGFBP-4 and PAPP-A in normal physiology and disease.
Hjortebjerg R
Growth Horm IGF Res; 2018 Aug; 41():7-22. PubMed ID: 29864720
[TBL] [Abstract][Full Text] [Related]
16. PAPP-A and cancer.
Conover CA; Oxvig C
J Mol Endocrinol; 2018 Jul; 61(1):T1-T10. PubMed ID: 29844094
[TBL] [Abstract][Full Text] [Related]
17. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
Harrington SC; Simari RD; Conover CA
Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs.
Boldt HB; Conover CA
Growth Horm IGF Res; 2007 Feb; 17(1):10-8. PubMed ID: 17218136
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty.
Bayes-Genis A; Schwartz RS; Lewis DA; Overgaard MT; Christiansen M; Oxvig C; Ashai K; Holmes DR; Conover CA
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):335-41. PubMed ID: 11231911
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
Ortiz CO; Chen BK; Bale LK; Overgaard MT; Oxvig C; Conover CA
J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
